Increased use of antimicrobial medication in bulimia nervosa and binge‐eating disorder prior to the eating disorder treatment

Raevuori, Anu; Lukkariniemi, Laura; Suokas, Jaana; Gissler, Mika; Suvisaari, Jaana; Haukka, Jari

doi:10.1002/eat.22497

Cited by 15 publications

(15 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Reports also show that dementia is related to peripheral pro-inflammatory factors released by periodontal inflammatory mediators such as C-reactive protein, IL-6, haptoglobin, TNF-α, and fibrinogen ( 76 – 78 ). Furthermore, some studies have also found that inflammation play an important role in eating disorders ( 79 , 80 ) and sleep disorders ( 81 – 83 ).…”

Section: Discussionmentioning

confidence: 99%

Increased Risk of Psychiatric Disorders in Allergic Diseases: A Nationwide, Population-Based, Cohort Study

et al. 2018

View full text Add to dashboard Cite

Background/objectiveAllergic diseases, such as bronchial asthma, allergic rhinitis, atopic dermatitis, and psychiatric disorders, are major health issues. There have been reports that allergic diseases were associated with depression or anxiety disorders. This study aimed to investigate the association between these allergic diseases and the risk of developing overall psychiatric disorders in patients from Taiwan.MethodsThis cohort study used the database of the Taiwan National Health Insurance Program. A total of 186,588 enrolled patients, with 46,647 study subjects who had suffered from allergic diseases, and 139,941 controls matched for sex and age, from the Longitudinal Health Insurance Dataset of 2000–2015, were selected from a sub-dataset of the National Health Insurance Research Database. Fine and Gray’s competing risk model analysis was used to explore the hazard ratio (HR), and 95% confidence interval, for the risk of allergic diseases being associated with the risk of developing psychiatric disorders during the 15 years of follow-up.ResultsOf the study subjects, 5,038 (10.8%) developed psychiatric disorders when compared to 9,376 (6.7%) in the control group, with significant difference (p < 0.001). Fine and Gray’s competing risk model analysis revealed that the adjusted HR was 1.659 (95% CI = 1.602–1.717, p < 0.001). In this study, we found that the groups of atopic dermatitis alone and the allergic rhinitis + atopic dermatitis were associated with a lower risk of psychiatric disorders, but all the other four groups, such as bronchial asthma alone, allergic rhinitis alone, bronchial asthma + allergic rhinitis, bronchial asthma + atopic dermatitis, and the combination of all these three allergic diseases, were associated with a higher risk of psychiatric disorders.ConclusionAllergic diseases are therefore associated with a 1.66-fold increased hazard of psychiatric disorders in Taiwan.

show abstract

Section: Discussionmentioning

confidence: 99%

Increased Risk of Psychiatric Disorders in Allergic Diseases: A Nationwide, Population-Based, Cohort Study

et al. 2018

View full text Add to dashboard Cite

show abstract

“…Escherichia coli K12 and Body Mass Index (Million et al, 2013). Bulimia nervosa (BN) and binge-eating disorder (BED) diagnoses on the other hand have been correlated to antimicrobial medication use prior to ED treatment (Raevuori et al, 2016).…”

Section: Gut Microbiota Dysbiosis and Edsmentioning

confidence: 99%

The Microbiota, the Gut and the Brain in Eating and Alcohol Use Disorders: A ‘Ménage à Trois’?

Temko

Bouhlal

Farokhnia

et al. 2017

Alcohol and Alcoholism

View full text Add to dashboard Cite

Aims: Accumulating evidence for the influence of the gut microbiota on the bidirectional communication along the gut-brain axis suggests a role of the gut microbiota in eating disorders (EDs) and alcohol and substance use disorders. The potential influence of altered gut microbiota (dysbiosis) on behaviors associated with such disorders may have implications for developing therapeutic interventions. Methods: A systematic review of preclinical and clinical studies evaluating the gut microbiota, EDs and alcohol and substance use disorders was conducted using MEDLINE, Embase and Web of Science databases with the objective being to examine the role of the gut microbiota in behavioral correlates of these disorders. Original papers focused on the gut microbiota and potential behavioral implications were deemed eligible for consideration. Results: The resulting 12 publications were limited to gut microbiota studies related to EDs and alcohol and substance use disorders. Some studies suggest that dysbiosis and gut microbial byproducts may influence the pathophysiology of EDs via direct and indirect interference with peptide hormone signaling. Additionally, dysbiosis was shown to be correlated with alcohol use disorder-related symptoms, i.e. craving, depression and anxiety. Finally, a mouse study suggests that manipulations in the gut microbiota may affect cocaine-related behaviors. Conclusions: Promising, albeit preliminary, findings suggest a potential role of the gut microbiota in behavioral correlates of EDs and alcohol and substance use disorders. Short summary: Preliminary evidence exists supporting the role of the gut microbiota in eating disorders and alcohol and substance use disorders, although additional investigation is needed to determine what is causative versus epiphenomenological.

show abstract

“…Several studies suggest that both obesity and underweight can increase the risk of viral infection in a Ushaped manner, which holds in particular for influenzarelated pneumonia [1]. Paradoxically, despite serious malnourishment and alterations in immune functions, it has been reported that anorexia nervosa (AN) seems to be associated with fewer symptomatic viral infections [2][3][4]. However, because of the paucity, contradictions and methodological shortcomings of previous studies [2][3][4][5], extreme care must be taken in drawing any firm conclusion.…”

Section: The Risk Of Covid-19 Infection In Patients With Ed -Safety Recommendationsmentioning

confidence: 99%

COVID-19, anorexia nervosa and obese patients with an eating disorder - some considerations for practitioners and researchers

2021

View full text Add to dashboard Cite

show abstract

Increased use of antimicrobial medication in bulimia nervosa and binge‐eating disorder prior to the eating disorder treatment

Cited by 15 publications

References 44 publications

Increased Risk of Psychiatric Disorders in Allergic Diseases: A Nationwide, Population-Based, Cohort Study

Increased Risk of Psychiatric Disorders in Allergic Diseases: A Nationwide, Population-Based, Cohort Study

The Microbiota, the Gut and the Brain in Eating and Alcohol Use Disorders: A ‘Ménage à Trois’?

COVID-19, anorexia nervosa and obese patients with an eating disorder - some considerations for practitioners and researchers

Contact Info

Product

Resources

About